Page last updated: 2024-12-06

sesamin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Sesamin is a lignan found in sesame seeds. It is a natural compound that has been shown to have various beneficial effects on human health. It is known to be synthesized through the enzymatic coupling of two molecules of pinoresinol. Sesamin is of interest to researchers because of its potential to:
- Improve cardiovascular health by lowering cholesterol levels and reducing blood pressure.
- Possess anti-inflammatory properties.
- Enhance brain function and cognitive abilities.
- Protect against certain types of cancer.
- Promote healthy aging.'

(+)-sesamin : A lignan that consists of tetrahydro-1H,3H-furo[3,4-c]furan substituted by 1,3-benzodioxole groups at positions 1 and 4 (the 1S,3aR,4S,6aR stereoisomer). Isolated from Cinnamomum camphora, it exhibits cytotoxic activity. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
Camphoragenusa component of Guanxingao, a kind of traditional Chinese rubber electuary medicine which is able to either cure or guard against coronary heart disease and angina pectoris[MeSH]LauraceaeA family of mainly aromatic evergreen plants in the order Laurales. The laurel family includes 2,200 species in 45 genera and from these are derived medicinal extracts, essential oils, camphor and other products.[MeSH]
Cinnamomum camphoraspeciesA tree, Cinnamomum camphora (L.) J. Presl, known as the source of CAMPHOR.[MeSH]LauraceaeA family of mainly aromatic evergreen plants in the order Laurales. The laurel family includes 2,200 species in 45 genera and from these are derived medicinal extracts, essential oils, camphor and other products.[MeSH]

Cross-References

ID SourceID
PubMed CID72307
CHEMBL ID252915
CHEBI ID66470
SCHEMBL ID94517
MeSH IDM0153023

Synonyms (83)

Synonym
nsc-36403
pseudo cubebin
d-sesamin
sesamin, (+)-
fagarol
d-(+)-sesamin
sezamin
5-[(3s,3ar,6s,6ar)-6-(1,3-benzodioxol-5-yl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-1,3-benzodioxole
1,3-benzodioxole, 5,5'-(tetrahydro-1h,3h-furo[3,4-c]furan-1,4-diyl)bis-, (1s,3ar,4s,6ar)-
(+)-segamin
sesamin ,
607-80-7
(+)-sesamin
sesamin, >=95%, crystalline
smr000445559
MLS000728578
l-sesamin
nsc 36403
1h,3h-furo(3,4-c)furan, tetrahydro-1,4-bis(3,4-(methylenedioxy)phenyl)-, (1s,3ar,4s,6ar)-
ai3-00811
1,3-benzodioxole, 5,5'-(tetrahydro-1h,3h-furo(3,4-c)furan-1,4-diyl)bis-, (1s-(1alpha,3a alpha,4alpha,6a alpha))-
ACON0_000323
ACON1_002421
NCGC00169864-01
MLS002473316
CHEMBL252915
chebi:66470 ,
5-[(3s,3ar,6s,6ar)-3-(1,3-benzodioxol-5-yl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-6-yl]-1,3-benzodioxole
A832882
5,5'-(1s,3ar,4s,6ar)-tetrahydro-1h,3h-furo[3,4-c]furan-1,4-diylbis(1,3-benzodioxol)
NCGC00169864-02
SESAMIN - FAGAROL
HMS2232F11
5,5'-(1s,3ar,4s,6ar)-tetrahydro-1h,3h-furo[3,4-c]furan-1,4-diylbis(1,3-benzodioxole)
s7946o4p76 ,
unii-s7946o4p76
unii-fy3s29jvc9
1,3-benzodioxole, 5,5'-((1r,3as,4r,6as)-tetrahydro-1h,3h-furo(3,4-c)furan-1,4-diyl)bis-, rel-
1,3-benzodioxole, 5,5'-(tetrahydro-1h,3h-furo(3,4-c)furan-1,4-diyl)bis-, (1alpha,3aalpha,4alpha,6aalpha)-(+/-)-
1,3-benzodioxole, 5,5'-(tetrahydro-1h,3h-furo(3,4-c)furan-1,4-diyl)bis-, (1alpha,3aalpha,4alpha,6aalpha)-
rel-(7s,7's8r,8'r)-sesamin
sesamin, (+/-)-
(+/-)-sesamin
81602-22-4
sesamin dl-form [mi]
fy3s29jvc9 ,
S2392
sesamin d-form [mi]
1,3-benzodioxole, 5,5'-(tetrahydro-1h,3h-furo(3,4-c)furan-1,4-diyl)bis-, (1s-(1.alpha.,3a .alpha.,4.alpha.,6a .alpha.))-
5,5'-(tetrahydro-1h,3h-furo(3,4-c)furan-1,4-diyl)bis-1,3-benzodioxole
sesamin [who-dd]
tetrahydro-1,4-bis(3,4-(methylenedioxy)phenyl)-1h,3h-furo(3,4-c)furan
sesamin [mi]
1,3-benzodioxole, 5,5'-(tetrahydro-1h,3h-furo(3,4-c)furan-1,4-diyl)bis-, (1.alpha.,3a.alpha.,4.alpha.,6a.alpha.)-(+/-)-
rel-(7s,7's,8r,8'r)-sesamin
1,3-benzodioxole, 5,5'-(tetrahydro-1h,3h-furo(3,4-c)furan-1,4-diyl)bis-, (1.alpha.,3a.alpha.,4.alpha.,6a.alpha.)-
SCHEMBL94517
AKOS022168195
Q-100697
(1s,3ar,4s,6ar)-1,4-bis(benzo[d][1,3]dioxol-5-yl)tetrahydro-1h,3h-furo[3,4-c]furan
mfcd00216134
fsesamin
sr-01000777562
SR-01000777562-4
SR-01000777562-3
sesamin, analytical standard
sesamin, >=98% (hplc)
(1s,3ar,4s,6ar)-1,4-di(benzo[d][1,3]dioxol-5-yl)hexahydrofuro[3,4-c]furan
Q3511416
(1s,3ar,4s,6ar)-1,4-bis(benzo[d][1,3]dioxol-5-yl)hexahydrofuro[3,4-c]furan
HY-N0121
sesamin (fagarol)
sesamin,(s)
(1s,3ar,4s,6ar)-1,4-di(benzo[d][1,3]
dioxol-5-yl)hexahydrofuro[3,4-c]furan
AS-13527
CCG-268081
CS-0007831
gtpl11372
bdbm50542904
DTXSID301030528
5,5'-(1s,3ar,4s,6ar)-tetrahydro-1h,3h-furo(3,4-c)furan-1,4-diylbis(1,3-benzodioxole)
sesamin d-form

Research Excerpts

Overview

Sesamin is a lignan compound in plants that has various pharmacological effects. It reduces diabetes-associated injuries, regulates fatty acid and cholesterol metabolism, and exerts antiinflammatory and antitumour effects. Sesamin is a major component in lignans of sesame seeds.

ExcerptReferenceRelevance
"Sesamin is a lignan compound in plants that has various pharmacological effects, including reducing diabetes-associated injuries, regulating fatty acid and cholesterol metabolism, and exerting antiinflammatory and antitumour effects. "( Sesamin promotes apoptosis and pyroptosis via autophagy to enhance antitumour effects on murine T-cell lymphoma.
Jia, Z; Liu, H; Meng, Z; Sui, Y; Wang, Z; Zhang, J; Zhang, L; Zheng, Z, 2021
)
3.51
"Sesamin is a member of lignan family, which possesses estrogenic activity and plays a significant role in modulating bone homeostasis."( Sesamin Promotes Osteoporotic Fracture Healing by Activating Chondrogenesis and Angiogenesis Pathways.
Bai, S; Feng, L; Li, G; Li, Y; Lin, S; Lu, X; Tortorella, MD; Wang, H; Wang, M; Wang, Y; Yang, Z; Zhang, X, 2022
)
2.89
"Sesamin is a major lignan in sesame seeds, and a recent meta-analysis of controlled trials indicated that sesamin intake decreases blood pressure. "( In Vitro Inhibitory Effects of Sesamin on CYP4F2 Activity.
Aikawa, K; Kamijo, S; Ohmori, S; Watanabe, H; Yamaori, S, 2020
)
2.29
"Sesamin is a functional ingredient in sesame (Sesamum indicum) seeds and has many physiological effects. "( Sesame lignans suppress age-related disorders of the kidney in mice.
Amano, A; Ishigami, A; Kishimoto, Y; Ono, Y; Rogi, T; Sato, A; Shibata, H; Shimoyoshi, S; Takemoto, D, 2020
)
2
"Sesamin is a major component in lignans of sesame seeds, has been described to possess a lot of biological activity. "( Sesamin attenuates carrageenan-induced lung inflammation through upregulation of A20 and TAX1BP1 in rats.
Bai, J; Han, Q; Li, J; Li, L; Sun, L; Wang, Y; Wu, L; Yang, Z; Ye, H, 2020
)
3.44
"Sesamin is a well-known antioxidant extracted from sesame seeds that exhibits various curative effects. "( Sesamin protects SH-SY5Y cells against mechanical stretch injury and promoting cell survival.
Chen, H; Ding, J; Liu, Y; Tian, H; Xu, Z; Yang, D; Yuan, F, 2017
)
3.34
"Sesamin is a major lignan in sesame seeds and oil. "( Mechanisms of chromosomal aberrations induced by sesamin metabolites in Chinese hamster lung cells.
Hori, H; Kitagawa, Y; Ono, Y; Shibata, H; Tomimori, N, 2017
)
2.15
"Sesamin is a promising phytochemical agent inhibiting osteoclast differentiation and function."( Inhibitory effects of sesamin on human osteoclastogenesis.
Kongtawelert, P; Phitak, T; Pothacharoen, P; Wanachewin, O, 2017
)
1.49
"Sesamin is a major lignan constituent of sesame and possesses various health-promoting effects. "( Sesamin suppresses aging phenotypes in adult muscular and nervous systems and intestines in a Drosophila senescence-accelerated model.
Hirai, J; Inoue, YH; Le, TD; Nakahara, Y; Nakai, M; Okumura, K; Ono, Y; Sato, Y; Shibata, H; Takemoto, D; Tomimori, N; Ueda, M, 2019
)
3.4
"Sesamin is a furofuran-type lignan that is found abundantly in seeds of Sesamum indicum (sesame) and has been widely accepted as a dietary supplement with positive effects on human health. "( Identification of a binding protein for sesamin and characterization of its roles in plant growth.
Azuma, T; Furukawa, A; Hori, K; Horikawa, M; Kabe, Y; Koyama, T; Mori, S; Murata, J; Okazawa, A; Ono, E; Satake, H; Suematsu, M; Tera, M; Watanabe, T, 2019
)
2.22
"Sesamin is a potent modulator for LC-PUFA biosynthesis in animals, but probably will have more effective impact at advanced ages."( Sesamin modulation of lipid class and fatty acid profile in early juvenile teleost, Lates calcarifer, fed different dietary oils.
Alhazzaa, R; Bridle, AR; Carter, CG; Nichols, PD, 2012
)
2.54
"(-)-Sesamin is a lignan present in sesam oil and a number of medicinal plants. "( The lignan, (-)-sesamin reveals cytotoxicity toward cancer cells: pharmacogenomic determination of genes associated with sensitivity or resistance.
Efferth, T; Khalid, H; Saeed, M; Sugimoto, Y, 2014
)
1.31
"Sesamin is a natural polyphenolic compound with strong anti-oxidative effects."( Protective effects of the polyphenol sesamin on allergen-induced T(H)2 responses and airway inflammation in mice.
Kao, ST; Lee, CC; Lin, CH; Shen, ML; Wu, DC; Zhou, N, 2014
)
1.4
"Sesamin is an active constituent of Sesamum indicum which has been shown to possess multiple pharmacological activities."( Sesamin enhances cholesterol efflux in RAW264.7 macrophages.
Guo, P; Liu, N; Sun, L; Wu, C; Zheng, J, 2014
)
2.57
"Sesamin is a major component in lignans of sesame seed oil, known to possess potent anti-oxidative capacity. "( Sesamin increases heme oxygenase-1 protein in RAW 264.7 macrophages through inhibiting its ubiquitination process.
Egusa, K; Fukunaga, M; Inoue, A; Kawakami, T; Motomura, M; Ohnishi, M; Shiratsuchi, A; Takahashi, M; Urasaki, T, 2014
)
3.29
"Sesamin is a major lignan in sesame seeds and has various physiological effects. "( Absorption, distribution, metabolism, and excretion of [
Rogi, T; Shibata, H; Tomimori, N, 2017
)
1.9
"Sesamin is a lignan compound and the active constituent of sesame oil with antioxidant and anti-inflammatory properties."( Sesamin imparts neuroprotection against intrastriatal 6-hydroxydopamine toxicity by inhibition of astroglial activation, apoptosis, and oxidative stress.
Baluchnejadmojarad, T; Ghalami, J; Mansouri, M; Mokhtari, Z; Roghani, M, 2017
)
2.62
"Sesamin is a sesame component with antihypertensive and antioxidative activities and has recently aroused much interest in studying its potential anticancer application. "( Sesamin inhibits macrophage-induced vascular endothelial growth factor and matrix metalloproteinase-9 expression and proangiogenic activity in breast cancer cells.
Chang, CC; Huang, TS; Lee, CC; Lin, SJ; Liu, KJ; Wu, YC, 2011
)
3.25
"Sesamin is a major lignan that is present in sesame seeds and oil. "( Genotoxicity evaluation of sesamin and episesamin.
Fujii, W; Hori, H; Kamada, Y; Kitagawa, Y; Nagao, M; Ono, Y; Sakakibara, Y; Shibata, H; Shimoyoshi, S; Takayanagi, T, 2011
)
2.11
"Sesamin is a major lignan in sesame seed. "( The mechanism underlying the synergetic hypocholesterolemic effect of sesamin and α-tocopherol in rats fed a high-cholesterol diet.
Kiso, Y; Ono, Y; Rogi, T; Tomimori, N, 2011
)
2.05
"Sesamin is a well-known antioxidant from sesame seeds and it scavenges free radicals in several brain injury models."( Sesamin ameliorates oxidative stress and mortality in kainic acid-induced status epilepticus by inhibition of MAPK and COX-2 activation.
Chang, MH; Chao, YY; Hou, CW; Hsieh, PF; Jeng, KC; Lin, CH; Peng, YF; Shen, ML; Wu, SP; Yao, PW, 2011
)
2.53
"Sesamin is a major lignan found in sesame and is known to have various biological effects. "( How is sesamin metabolised in the human liver to show its biological effects?
Sakaki, T; Yasuda, K, 2012
)
2.28
"Episesamin is an isomer of sesamin, resulting from the refining process of non-roasted sesame seed oil. "( Identification of the metabolites of episesamin in rat bile and human liver microsomes.
Kiso, Y; Kitagawa, Y; Nakai, M; Ono, Y; Shibata, H; Tomimori, N, 2012
)
1.27
"Sesamin is an abundant phytochemical found in sesame seed oil that also shows antiproliferative and antiangiogenic activity against human breast cancer cells."( Mechanisms mediating the synergistic anticancer effects of combined γ-tocotrienol and sesamin treatment.
Akl, MR; Ayoub, NM; Sylvester, PW, 2012
)
1.32
"Sesamin is a major lignan constituent of sesame and possesses multiple functions such as antihypertensive, cholesterol-lowering, lipid-lowering and anticancer activities. "( Sesamin, a lignan of sesame, down-regulates cyclin D1 protein expression in human tumor cells.
Enoki-Konishi, M; Hitomi, T; Kawanaka, M; Koyama, M; Matsuzaki, Y; Nishikawa, A; Nishino, H; Okuyama, Y; Osawa, T; Sakai, T; Takayasu, J; Yokota, T, 2007
)
3.23
"Sesamin is a specific inhibitor of delta 5 desaturation, the conversion from dihomo-gamma-linolenic acid (20:3, n-6) to arachidonic acid (AA, 20:4, n-6). "( Interaction of sesamin and eicosapentaenoic acid against delta 5 desaturation and n-6/n-3 ratio of essential fatty acids in rat.
Igarashi, O; Takahashi, N; Umeda-Sawada, R, 1995
)
2.09

Effects

Sesamin has been shown to be a chondroprotective agent in osteoarthritis models. Sesamin exerts anti-oxidant and anti-inflammatory properties.

ExcerptReferenceRelevance
"Sesamin has been reported to interfere with NDs progression through its antioxidative, antiinflammatory, and antiapoptotic actions in most of the retrieved studies. "( The Role of Sesamin in Targeting Neurodegenerative Disorders: A Systematic Review.
Beirak Olia, MD; Emami, SA; Ghaderi, MA; Javadi, B, 2023
)
2.73
"Sesamin has potential for use as a skin protection agent in antiphotodamage and skin care products."( Protective Effects of Sesamin against UVB-Induced Skin Inflammation and Photodamage In Vitro and In Vivo.
Chang, QX; Chiang, HM; Chien, TY; Hou, CW; Lin, CY; Lin, TY; Wen, KC; Wu, PY, 2019
)
1.55
"Sesamin (SES) has the ameliorating effect on L02 hepatocyte model of insulin resistance induced by high glucose and high insulin, based on insulin receptor signaling pathway IRS/PI3K/Akt. "( Ameliorating effect of sesamin on insulin resistance of hepatic L02 cells induced by high glucose/high insulin.
Dongya, C; Hong, L; Jing, W; Mengxi, W; Mo, L; Renjie, Z, 2019
)
2.27
"Sesamin has many pharmacological effects, including supplying calcium."( Sesamin Promotes Osteoblastic Differentiation and Protects Rats from Osteoporosis.
Ma, ZP; Yang, Y; Yang, YF; Zhang, ZF, 2019
)
2.68
"Sesamin has been shown to have protection to several models of neurodegenerative diseases by its antioxidant and anti-inflammatory properties."( Protective effect of a sesamin derivative, 3-bis (3-methoxybenzyl) butane-1, 4-diol on Aβ-stressed PC12 cells.
Chang, SY; Hou, CW; Jeng, KC, 2015
)
1.45
"Sesamin has been described to exert anti-oxidant and anti-inflammatory properties. "( Sesamin ameliorates lipopolysaccharide/d-galactosamine-induced fulminant hepatic failure by suppression of Toll-like receptor 4 signaling in mice.
Chen, R; Gong, X; Jiang, R; Kuang, G; Ma, L; Wan, J, 2015
)
3.3
"Sesamin has been demonstrated to possess antioxidative activity."( Sesamin Ameliorates Advanced Glycation End Products-Induced Pancreatic β-Cell Dysfunction and Apoptosis.
Deng, RY; Guo, LQ; Kong, X; Ma, MZ; Su, Q; Wang, GD; Yang, JR; Zhang, JX, 2015
)
2.58
"Sesamin has been shown to be a chondroprotective agent in osteoarthritis models."( Ex vivo model exhibits protective effects of sesamin against destruction of cartilage induced with a combination of tumor necrosis factor-alpha and oncostatin M.
Boonmaleerat, K; Khansai, M; Kongtawelert, P; Phitak, T; Pothacharoen, P, 2016
)
1.42
"Sesamin has been shown to inhibit lipid peroxidation and regulate cytokine production."( Sesamin inhibits bacterial formylpeptide-induced inflammatory responses in a murine air-pouch model and in THP-1 human monocytes.
Chen, J; Cui, Y; Hou, X; Le, Y; Xie, L; Yang, L, 2010
)
2.52
"Episesamin has two methylendioxyphenyl groups on exo and endo faces of the bicyclic skeleton."( Identification of the metabolites of episesamin in rat bile and human liver microsomes.
Kiso, Y; Kitagawa, Y; Nakai, M; Ono, Y; Shibata, H; Tomimori, N, 2012
)
1.16
"Sesamin has hypoglycaemic, hypolipidaemic and the ability to ameliorate insulin resistance in KK-Ay mice, which might be related to its effect on insulin receptors, and thus increases insulin sensitivity."( Hypoglycaemic and hypolipidaemic activities of sesamin from sesame meal and its ability to ameliorate insulin resistance in KK-Ay mice.
Hong, L; Juncheng, H; Liangliang, C; Qin, W; Xiaoxiang, Z; Yi, W, 2013
)
2.09
"As sesamin itself has no antioxidative properties in vitro, to elucidate the mechanism of its antioxidative effects, the reaction products of sesamin in rat liver homogenate were analyzed."( Novel antioxidative metabolites in rat liver with ingested sesamin.
Akimoto, K; Harada, M; Kiso, Y; Miki, W; Nakahara, K; Nakai, M; Shibata, H, 2003
)
1.08
"Sesamin has been proved to be antihypertensive. "( Sesamin induces nitric oxide and decreases endothelin-1 production in HUVECs: possible implications for its antihypertensive effect.
Chen, PR; Chen, WW; Lee, CC; Lin, S; Shyu, KG; Tsai, CE; Tsai, SC; Wang, BW, 2004
)
3.21
"(+)-Sesamin has been of rapidly growing interest because of its beneficial biological effects in mammals, but its biosynthesis and physiological roles in plants remain to be clarified."( Formation of two methylenedioxy bridges by a Sesamum CYP81Q protein yielding a furofuran lignan, (+)-sesamin.
Fukuchi-Mizutani, M; Fukui, Y; Katsuta, M; Nakai, M; Ono, E; Saito, M; Satake, H; Tanaka, T; Tanaka, Y; Tomimori, N; Umezawa, T, 2006
)
1.03

Actions

Sesamin could activate cAMP response element (CRE) binding protein (CREB) It had no effect on the phosphorylation of p38 mitogen-activated protein kinase (MAPK) or Akt. Sesamin alone might increase formation of type II collagen and PGs.

ExcerptReferenceRelevance
"Sesamin could activate cAMP response element (CRE) binding protein (CREB), but it had no effect on the phosphorylation of p38 mitogen-activated protein kinase (MAPK) or Akt."( Sesamin induces melanogenesis by microphthalmia-associated transcription factor and tyrosinase up-regulation via cAMP signaling pathway.
Deng, P; He, G; Huang, J; Jiang, Z; Li, S; Liu, Y, 2011
)
2.53
"Sesamin alone might increase formation of type II collagen and PGs in the cartilage tissue of control rats."( Chondroprotective and anti-inflammatory effects of sesamin.
Caterson, B; Kongtawelert, P; Phitak, T; Poompimol, W; Pothacharoen, P; Settakorn, J, 2012
)
1.35
"Sesamin was found to inhibit this enzyme as measured in both spectrophotometric and radioactive assays."( Sesamin inhibits lysophosphatidylcholine acyltransferase in Mortierella alpina.
Chatrattanakunchai, S; Fraser, T; Stobart, K, 2000
)
2.47

Treatment

Sesamin treatment significantly decreased the number of differentiated osteoclasts observed by TRAP staining. Treatment with sesamin caused cell cycle arrest at G1 phase and inhibited cyclin D1 and CDK2 expression. Sesamin significantly ameliorated myocardial injury in rats.

ExcerptReferenceRelevance
"Sesamin treatment (30 mg/kg/day; P.O.) was started simultaneously with Pb acetate exposure (500 ppm in standard drinking water) in rats, and they continued for eight consecutive weeks."( Sesamin: Insights into its protective effects against lead-induced learning and memory deficits in rats.
Ghaderi, S; Khoshnam, SE; Rashno, M; Sarkaki, A, 2022
)
3.61
"The sesamin treatment attenuated mitogen-activated protein (MAP) kinase phosphorylation and matrix metalloproteinase (MMPs) overexpression induced by UVB exposure, and it significantly enhanced the tissue inhibitor of metalloproteinase-1 protein expression."( Protective Effects of Sesamin against UVB-Induced Skin Inflammation and Photodamage In Vitro and In Vivo.
Chang, QX; Chiang, HM; Chien, TY; Hou, CW; Lin, CY; Lin, TY; Wen, KC; Wu, PY, 2019
)
1.31
"Sesamin treatment did not significantly alter the renal CP concentration."( Ameliorative effect of sesamin in cisplatin-induced nephrotoxicity in rats by suppressing inflammation, oxidative/nitrosative stress, and cellular damage.
Al Salam, S; Al Suleimani, Y; Al Tobi, M; Al Za'abi, M; Ali, BH; Ashique, M; Manoj, P; Nemmar, A; Sudhadevi, M, 2020
)
1.59
"Sesamin-treated human oral cancer cell lines FaDu, HSC-3, and Ca9-22 were subjected to a wound-healing assay. "( Antimetastatic Effects of Sesamin on Human Head and Neck Squamous Cell Carcinoma through Regulation of Matrix Metalloproteinase-2.
Chen, JM; Chen, PY; Hsieh, MC; Lin, CC; Lin, JT, 2020
)
2.3
"Sesamin treatment reversed the activities of immune-related enzymes and the expressions of immune-related genes in liver exposed to fluoride."( Sesamin attenuates histological alterations, oxidative stress and expressions of immune-related genes in liver of zebrafish (Danio rerio) exposed to fluoride.
Cao, J; Chen, J; Feng, C; Guo, W; He, X; Li, L; Luo, Y; Meng, R; Wang, G; Wang, T; Wu, Y; Xie, L; Yun, S, 2020
)
2.72
"Sesamin treatment or depletion of TRIM44 markedly reduced ESCC cell proliferation."( Sesamin exerts anti-tumor activity in esophageal squamous cell carcinoma via inhibition of TRIM44 and NF-κB signaling.
Cai, B; Gu, L; Mao, W; Wen, L; Xu, L, 2022
)
2.89
"Sesamin treatment significantly decreased the number of differentiated osteoclasts observed by TRAP staining; however, sesamin inhibition did not result from the alteration of precursor cell proliferation."( Inhibitory effects of sesamin on human osteoclastogenesis.
Kongtawelert, P; Phitak, T; Pothacharoen, P; Wanachewin, O, 2017
)
1.49
"Sesamin treatment also prevented stressed-induced memory impairments and neuronal damages."( (+)-Sesamin attenuates chronic unpredictable mild stress-induced depressive-like behaviors and memory deficits via suppression of neuroinflammation.
Chu, C; Fu, S; Jia, M; Liu, X; Liu, Z; Pan, J; Wang, Q; Zhao, Y, 2019
)
1.79
"Sesamin treatment enhanced NO biosynthesis in SHR aortas was due to upregulated P-eNOS and suppressed eNOS uncoupling, and the latter effect might be attributed to decreased nitrotyrosine and upregulated DHFR."( Sesamin enhances nitric oxide bioactivity in aortas of spontaneously hypertensive rats.
Chen, XP; Guo, LQ; Kong, X; Li, W; Liu, WY; Yang, JR; Zhang, JX, 2015
)
2.58
"Sesamin treatment obviously ameliorated AGE-induced β-cell dysfunction and apoptosis both in vivo and in vitro."( Sesamin Ameliorates Advanced Glycation End Products-Induced Pancreatic β-Cell Dysfunction and Apoptosis.
Deng, RY; Guo, LQ; Kong, X; Ma, MZ; Su, Q; Wang, GD; Yang, JR; Zhang, JX, 2015
)
2.58
"Sesamin treatment reduced systolic blood pressure, improved vasodilatation induced by acetylcholine and enhanced NO bioactivity in the thoracic aortas."( Sesamin improves endothelial dysfunction in renovascular hypertensive rats fed with a high-fat, high-sucrose diet.
Guo, LQ; Huang, K; Kong, X; Wu, XQ; Xiong, Y; Yang, JR; Zhou, Y, 2009
)
2.52
"Treatment with sesamin caused cell cycle arrest at G1 phase and inhibited cyclin D1 and CDK2 expression."( Sesamin suppresses NSCLC cell proliferation and induces apoptosis via Akt/p53 pathway.
Chen, Y; Huang, H; Li, H; Liu, B; Lu, C; Qi, W; Yang, Z; Zhang, L; Zhang, W, 2020
)
2.34
"Treatment with sesamin remarkably attenuated fluoride-induced liver damage in a dose-dependent manner, indicated by the histopathological observation."( Sesamin attenuates histological alterations, oxidative stress and expressions of immune-related genes in liver of zebrafish (Danio rerio) exposed to fluoride.
Cao, J; Chen, J; Feng, C; Guo, W; He, X; Li, L; Luo, Y; Meng, R; Wang, G; Wang, T; Wu, Y; Xie, L; Yun, S, 2020
)
2.34
"Pretreatment with sesamin significantly ameliorated myocardial injury in rats which induced myocardial ischemia and reperfusion injury by reduced levels of serum c TnⅠand LDH( P <0. "( [Sesamin Preconditioning Attenuates Myocardial Ischemia Reperfusion Injury in Rats Through Activation of Akt/eNOS Signaling Pathway].
Ren, YN; Tao, SJ; Tu, PC; Zhao, MQ; Zheng, SG, 2016
)
1.68
"Pretreatment with sesamin effectively ameliorated myocardial ischemia reperfusion injury in rats, and the mechanism might be related to enhancing its antioxidant capacity and the activation of Akt / eNOS signaling pathway and subsequent increase of NO synthesis and suppression of cardiac myocyte apoptosis."( [Sesamin Preconditioning Attenuates Myocardial Ischemia Reperfusion Injury in Rats Through Activation of Akt/eNOS Signaling Pathway].
Ren, YN; Tao, SJ; Tu, PC; Zhao, MQ; Zheng, SG, 2016
)
1.68
"Treatment with sesamin (10 μM) significantly enhanced cholesterol efflux mediated by high-density lipoprotein (HDL)."( Sesamin enhances cholesterol efflux in RAW264.7 macrophages.
Guo, P; Liu, N; Sun, L; Wu, C; Zheng, J, 2014
)
2.18
"Treatment with sesamin significantly reduced the expression of nuclear NF-κB, IL-6, p-Stat3, Twist and Vimentin (a mesenchymal marker) in SP cells."( Differentiation therapy: sesamin as an effective agent in targeting cancer stem-like side population cells of human gallbladder carcinoma.
Gong, W; Guo, LQ; Kong, X; Ma, MZ; Quan, ZW; Su, Q; Wang, GD; Weng, MZ; Yang, JR; Zhang, JX; Zhang, Y, 2014
)
1.05
"Co-treatment with sesamin decreased ubiquitinated HO-1 protein accumulation by MG-132."( Sesamin increases heme oxygenase-1 protein in RAW 264.7 macrophages through inhibiting its ubiquitination process.
Egusa, K; Fukunaga, M; Inoue, A; Kawakami, T; Motomura, M; Ohnishi, M; Shiratsuchi, A; Takahashi, M; Urasaki, T, 2014
)
2.17
"Pretreatment with sesamin for 48 h caused a significant increase in MDR1 mRNA expression without a significant effect on the expression of P-glycoprotein or accumulation of rhodamine 123."( Effects of dietary ingredients on function and expression of P-glycoprotein in human intestinal epithelial cells.
Ibe, M; Okura, T; Shinozuka, K; Umegaki, K; Yamada, S, 2010
)
0.68
"Treatment with sesamin extract (30 mg/kg) significantly increased plasma α-tocopherol level 50% and 55.8% from rats without and with KA treatment, respectively. "( Sesamin ameliorates oxidative stress and mortality in kainic acid-induced status epilepticus by inhibition of MAPK and COX-2 activation.
Chang, MH; Chao, YY; Hou, CW; Hsieh, PF; Jeng, KC; Lin, CH; Peng, YF; Shen, ML; Wu, SP; Yao, PW, 2011
)
2.16
"Treatment with sesamin (120 and 60mg/kg⁻¹·d⁻¹) in 2K1C rats on HFS diet improved renal function, corrected structural abnormalities, and attenuated renal oxidative stress."( Sesamin exerts renoprotective effects by enhancing NO bioactivity in renovascular hypertensive rats fed with high-fat-sucrose diet.
Huang, K; Kong, X; Li, XL; Wu, XQ; Yang, JR; Zhou, Y, 2012
)
2.16
"Treatment with sesamin (100 or 50 mg kg(-1)) significantly decreased the level of fasting plasma glucose, glycosylated serum protein, serum insulin, triglycerides, cholesterol, free fatty acid and malondialdehyde content of livers. "( Hypoglycaemic and hypolipidaemic activities of sesamin from sesame meal and its ability to ameliorate insulin resistance in KK-Ay mice.
Hong, L; Juncheng, H; Liangliang, C; Qin, W; Xiaoxiang, Z; Yi, W, 2013
)
1
"Treatment with sesamin for seven weeks resulted in prophylactic effects on rotenone-induced parkinsonian bradykinesia and catalepsy, and the effects were equivalent to ASH effects."( Effect of sesamin in Acanthopanax senticosus HARMS on behavioral dysfunction in rotenone-induced parkinsonian rats.
Fujikawa, T; Hayashi, I; Kanada, N; Nakashima, K; Ogata, M; Shimada, A; Suzuki, I, 2005
)
1.07

Toxicity

ExcerptReferenceRelevance
" No serious adverse events were observed in this study."( Pharmacokinetics and safety of the sesame lignans, sesamin and episesamin, in healthy subjects.
Fujii, W; Kitagawa, Y; Sakakibara, Y; Shibata, H; Tanaka, Y; Tomimori, N, 2013
)
0.64
" These findings demonstrated that, among three sesame lignans tested, sesamin protected against Aβ toxicity by reducing toxic Aβ oligomers."( Sesamin and sesamolin reduce amyloid-β toxicity in a transgenic Caenorhabditis elegans.
Bunargin, W; Keowkase, R; Shoomarom, N; Sitthithaworn, W; Weerapreeyakul, N, 2018
)
2.16
" The addition of dietary polyphenols did not increase adverse events."( Efficacy and safety of dietary polyphenols in rheumatoid arthritis: A systematic review and meta-analysis of 47 randomized controlled trials.
Chen, Y; Deng, Y; Guo, H; He, Q; Huang, Z; Li, H; Long, Z; Wei, H; Xiang, W; Xiao, W; Yang, K; Yuan, M; Yuan, X; Zeng, L, 2023
)
0.91

Bioavailability

differences in bioavailability may contribute to the divergent effects of sesamin and sesamolin on hepatic fatty acid oxidation. However, the bioavailability of sedamolin was poor in mice.

ExcerptReferenceRelevance
" This suggests that the bioavailability of gamma-tocopherol is enhanced in phenol-containing diets as compared with purified diets."( Sesamin (a compound from sesame oil) increases tocopherol levels in rats fed ad libitum.
Appelqvist, LA; Kamal-Eldin, A; Pettersson, D, 1995
)
1.73
" The increased bioavailability of tocopherols in the presence of dietary lignans might be due to the regeneration of oxidized tocopherols."( Dietary sesame oils inhibits iron-induced oxidative stress in rats [corrected].
Hemalatha, S; Raghunath, M, 2004
)
0.32
" Differences in bioavailability may contribute to the divergent effects of sesamin and sesamolin on hepatic fatty acid oxidation."( Comparative analysis of sesame lignans (sesamin and sesamolin) in affecting hepatic fatty acid metabolism in rats.
Adachi, Y; Ide, T; Lim, JS; Takahashi, Y, 2007
)
0.84
" Owing to a difference in the affinity of T3 and Toc for the α-tocopherol transfer protein, the bioavailability of orally ingested T3 is lower than that of Toc."( Synergistic Anticancer Effect of Tocotrienol Combined with Chemotherapeutic Agents or Dietary Components: A Review.
Eitsuka, T; Miyazawa, T; Nakagawa, K; Nishida, H; Tatewaki, N, 2016
)
0.43
" However, the bioavailability of sesamin and sesamolin was poor in mice."( Using Turmeric Oil as a Solvent Improves the Distribution of Sesamin-Sesamolin in the Serum and Brain of Mice.
Iwamoto, K; Makino, S; Matsumura, S; Moriyama, T; Yamamoto, A; Yoshioka, Y; Zaima, N, 2019
)
1.04

Dosage Studied

ExcerptRelevanceReference
" Asarinin can decrease the dosage of CsA."( [Effect of asarinin on the acute heart transplantation rejection and the expression of adhesion molecule].
Guan, ZZ; Lu, SF; Nie, HG; Yang, BF; Zhang, LL; Zhang, S, 2006
)
0.33
" However, their pharmacokinetic (PK) properties remain poorly characterized, and high dosage animal studies may provide further information on their in vivo functions and pharmacological effects."( Plasma and tissue concentrations of α-tocopherol and δ-tocopherol following high dose dietary supplementation in mice.
Baxter, LL; Incao, A; Marugan, JJ; McKew, JC; Pavan, WJ; Xiao, J; Zheng, W, 2012
)
0.38
" The best dosage to improve risk biomarkers of patients with T2DM and MetS is 30-35 ml daily of sesame oil or inclusion of sesame oil in daily dietary patterns up to 30% of total energy for 8-12 weeks and/or 200 mg daily of sesamin supplementation for eight weeks."( Therapeutic Effectiveness of Sesame Preparations and its Bioactive Ingredients in Management of Cardiometabolic Syndrome in Diabetes Mellitus: A Systematic Review.
Abbasi, MM; Mahmoodi, MR, 2023
)
1.09
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
neuroprotective agentAny compound that can be used for the treatment of neurodegenerative disorders.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
lignanAny phenylpropanoid derived from phenylalanine via dimerization of substituted cinnamic alcohols, known as monolignols, to a dibenzylbutane skeleton. Note that while individual members of the class have names ending ...lignane, ...lignene, ...lignadiene, etc., the class names lignan, neolignan, etc., do not end with an "e".
benzodioxoles
furofuranOrganic heterobicyclic compounds containing a two furan rings ortho-fused to each other.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
sesaminol glucoside biosynthesis58
sesamin biosynthesis013
sesaminol glucoside biosynthesis512
sesamin biosynthesis015

Protein Targets (11)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
thioredoxin reductaseRattus norvegicus (Norway rat)Potency89.12510.100020.879379.4328AID588453
nonstructural protein 1Influenza A virus (A/WSN/1933(H1N1))Potency2.81840.28189.721235.4813AID2326
vitamin D3 receptor isoform VDRAHomo sapiens (human)Potency79.43280.354828.065989.1251AID504847
chromobox protein homolog 1Homo sapiens (human)Potency14.12540.006026.168889.1251AID540317
serine/threonine-protein kinase PLK1Homo sapiens (human)Potency26.67950.168316.404067.0158AID720504
gemininHomo sapiens (human)Potency0.00520.004611.374133.4983AID624296
TAR DNA-binding protein 43Homo sapiens (human)Potency11.22021.778316.208135.4813AID652104
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Cytochrome P450 1A2Homo sapiens (human)Km15.00005.00007.00009.0000AID1209206
Cytochrome P450 2C9 Homo sapiens (human)Km5.40000.19002.43005.4000AID1209202
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (79)

Processvia Protein(s)Taxonomy
steroid catabolic processCytochrome P450 1A2Homo sapiens (human)
porphyrin-containing compound metabolic processCytochrome P450 1A2Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 1A2Homo sapiens (human)
cholesterol metabolic processCytochrome P450 1A2Homo sapiens (human)
estrogen metabolic processCytochrome P450 1A2Homo sapiens (human)
toxin biosynthetic processCytochrome P450 1A2Homo sapiens (human)
post-embryonic developmentCytochrome P450 1A2Homo sapiens (human)
alkaloid metabolic processCytochrome P450 1A2Homo sapiens (human)
regulation of gene expressionCytochrome P450 1A2Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 1A2Homo sapiens (human)
dibenzo-p-dioxin metabolic processCytochrome P450 1A2Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 1A2Homo sapiens (human)
lung developmentCytochrome P450 1A2Homo sapiens (human)
methylationCytochrome P450 1A2Homo sapiens (human)
monocarboxylic acid metabolic processCytochrome P450 1A2Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 1A2Homo sapiens (human)
retinol metabolic processCytochrome P450 1A2Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 1A2Homo sapiens (human)
cellular respirationCytochrome P450 1A2Homo sapiens (human)
aflatoxin metabolic processCytochrome P450 1A2Homo sapiens (human)
hydrogen peroxide biosynthetic processCytochrome P450 1A2Homo sapiens (human)
oxidative demethylationCytochrome P450 1A2Homo sapiens (human)
cellular response to cadmium ionCytochrome P450 1A2Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 1A2Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 2C9 Homo sapiens (human)
steroid metabolic processCytochrome P450 2C9 Homo sapiens (human)
cholesterol metabolic processCytochrome P450 2C9 Homo sapiens (human)
estrogen metabolic processCytochrome P450 2C9 Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 2C9 Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 2C9 Homo sapiens (human)
urea metabolic processCytochrome P450 2C9 Homo sapiens (human)
monocarboxylic acid metabolic processCytochrome P450 2C9 Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 2C9 Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 2C9 Homo sapiens (human)
amide metabolic processCytochrome P450 2C9 Homo sapiens (human)
icosanoid biosynthetic processCytochrome P450 2C9 Homo sapiens (human)
oxidative demethylationCytochrome P450 2C9 Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 2C9 Homo sapiens (human)
negative regulation of protein phosphorylationTAR DNA-binding protein 43Homo sapiens (human)
mRNA processingTAR DNA-binding protein 43Homo sapiens (human)
RNA splicingTAR DNA-binding protein 43Homo sapiens (human)
negative regulation of gene expressionTAR DNA-binding protein 43Homo sapiens (human)
regulation of protein stabilityTAR DNA-binding protein 43Homo sapiens (human)
positive regulation of insulin secretionTAR DNA-binding protein 43Homo sapiens (human)
response to endoplasmic reticulum stressTAR DNA-binding protein 43Homo sapiens (human)
positive regulation of protein import into nucleusTAR DNA-binding protein 43Homo sapiens (human)
regulation of circadian rhythmTAR DNA-binding protein 43Homo sapiens (human)
regulation of apoptotic processTAR DNA-binding protein 43Homo sapiens (human)
negative regulation by host of viral transcriptionTAR DNA-binding protein 43Homo sapiens (human)
rhythmic processTAR DNA-binding protein 43Homo sapiens (human)
regulation of cell cycleTAR DNA-binding protein 43Homo sapiens (human)
3'-UTR-mediated mRNA destabilizationTAR DNA-binding protein 43Homo sapiens (human)
3'-UTR-mediated mRNA stabilizationTAR DNA-binding protein 43Homo sapiens (human)
nuclear inner membrane organizationTAR DNA-binding protein 43Homo sapiens (human)
amyloid fibril formationTAR DNA-binding protein 43Homo sapiens (human)
regulation of gene expressionTAR DNA-binding protein 43Homo sapiens (human)
B cell apoptotic processProgrammed cell death protein 1Homo sapiens (human)
adaptive immune responseProgrammed cell death protein 1Homo sapiens (human)
negative regulation of tolerance inductionProgrammed cell death protein 1Homo sapiens (human)
negative regulation of T cell mediated immune response to tumor cellProgrammed cell death protein 1Homo sapiens (human)
negative regulation of B cell apoptotic processProgrammed cell death protein 1Homo sapiens (human)
apoptotic processProgrammed cell death protein 1Homo sapiens (human)
humoral immune responseProgrammed cell death protein 1Homo sapiens (human)
negative regulation of immune responseProgrammed cell death protein 1Homo sapiens (human)
negative regulation of T cell activationProgrammed cell death protein 1Homo sapiens (human)
regulatory T cell apoptotic processProgrammed cell death protein 1Homo sapiens (human)
regulation of immune responseProgrammed cell death protein 1Homo sapiens (human)
positive regulation of T cell apoptotic processProgrammed cell death protein 1Homo sapiens (human)
regulation of activated T cell proliferationProgrammed cell death 1 ligand 1Homo sapiens (human)
regulation of T cell apoptotic processProgrammed cell death 1 ligand 1Homo sapiens (human)
regulation of activated CD4-positive, alpha-beta T cell apoptotic processProgrammed cell death 1 ligand 1Homo sapiens (human)
adaptive immune responseProgrammed cell death 1 ligand 1Homo sapiens (human)
negative regulation of T cell mediated immune response to tumor cellProgrammed cell death 1 ligand 1Homo sapiens (human)
immune responseProgrammed cell death 1 ligand 1Homo sapiens (human)
signal transductionProgrammed cell death 1 ligand 1Homo sapiens (human)
cell surface receptor signaling pathwayProgrammed cell death 1 ligand 1Homo sapiens (human)
positive regulation of cell migrationProgrammed cell death 1 ligand 1Homo sapiens (human)
T cell costimulationProgrammed cell death 1 ligand 1Homo sapiens (human)
negative regulation of type II interferon productionProgrammed cell death 1 ligand 1Homo sapiens (human)
negative regulation of interleukin-10 productionProgrammed cell death 1 ligand 1Homo sapiens (human)
positive regulation of interleukin-10 productionProgrammed cell death 1 ligand 1Homo sapiens (human)
response to cytokineProgrammed cell death 1 ligand 1Homo sapiens (human)
TRIF-dependent toll-like receptor signaling pathwayProgrammed cell death 1 ligand 1Homo sapiens (human)
positive regulation of T cell proliferationProgrammed cell death 1 ligand 1Homo sapiens (human)
positive regulation of DNA-templated transcriptionProgrammed cell death 1 ligand 1Homo sapiens (human)
negative regulation of activated T cell proliferationProgrammed cell death 1 ligand 1Homo sapiens (human)
negative regulation of tumor necrosis factor superfamily cytokine productionProgrammed cell death 1 ligand 1Homo sapiens (human)
positive regulation of activated CD8-positive, alpha-beta T cell apoptotic processProgrammed cell death 1 ligand 1Homo sapiens (human)
negative regulation of CD4-positive, alpha-beta T cell proliferationProgrammed cell death 1 ligand 1Homo sapiens (human)
negative regulation of CD8-positive, alpha-beta T cell activationProgrammed cell death 1 ligand 1Homo sapiens (human)
cellular response to lipopolysaccharideProgrammed cell death 1 ligand 1Homo sapiens (human)
negative regulation of T cell proliferationProgrammed cell death 1 ligand 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (33)

Processvia Protein(s)Taxonomy
monooxygenase activityCytochrome P450 1A2Homo sapiens (human)
iron ion bindingCytochrome P450 1A2Homo sapiens (human)
protein bindingCytochrome P450 1A2Homo sapiens (human)
electron transfer activityCytochrome P450 1A2Homo sapiens (human)
oxidoreductase activityCytochrome P450 1A2Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 1A2Homo sapiens (human)
enzyme bindingCytochrome P450 1A2Homo sapiens (human)
heme bindingCytochrome P450 1A2Homo sapiens (human)
demethylase activityCytochrome P450 1A2Homo sapiens (human)
caffeine oxidase activityCytochrome P450 1A2Homo sapiens (human)
aromatase activityCytochrome P450 1A2Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 1A2Homo sapiens (human)
estrogen 2-hydroxylase activityCytochrome P450 1A2Homo sapiens (human)
hydroperoxy icosatetraenoate dehydratase activityCytochrome P450 1A2Homo sapiens (human)
monooxygenase activityCytochrome P450 2C9 Homo sapiens (human)
iron ion bindingCytochrome P450 2C9 Homo sapiens (human)
arachidonic acid epoxygenase activityCytochrome P450 2C9 Homo sapiens (human)
steroid hydroxylase activityCytochrome P450 2C9 Homo sapiens (human)
arachidonic acid 14,15-epoxygenase activityCytochrome P450 2C9 Homo sapiens (human)
arachidonic acid 11,12-epoxygenase activityCytochrome P450 2C9 Homo sapiens (human)
oxidoreductase activityCytochrome P450 2C9 Homo sapiens (human)
(S)-limonene 6-monooxygenase activityCytochrome P450 2C9 Homo sapiens (human)
(S)-limonene 7-monooxygenase activityCytochrome P450 2C9 Homo sapiens (human)
caffeine oxidase activityCytochrome P450 2C9 Homo sapiens (human)
(R)-limonene 6-monooxygenase activityCytochrome P450 2C9 Homo sapiens (human)
aromatase activityCytochrome P450 2C9 Homo sapiens (human)
heme bindingCytochrome P450 2C9 Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2C9 Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
double-stranded DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
RNA bindingTAR DNA-binding protein 43Homo sapiens (human)
mRNA 3'-UTR bindingTAR DNA-binding protein 43Homo sapiens (human)
protein bindingTAR DNA-binding protein 43Homo sapiens (human)
lipid bindingTAR DNA-binding protein 43Homo sapiens (human)
identical protein bindingTAR DNA-binding protein 43Homo sapiens (human)
pre-mRNA intronic bindingTAR DNA-binding protein 43Homo sapiens (human)
molecular condensate scaffold activityTAR DNA-binding protein 43Homo sapiens (human)
protein bindingProgrammed cell death protein 1Homo sapiens (human)
signaling receptor activityProgrammed cell death protein 1Homo sapiens (human)
transcription coactivator activityProgrammed cell death 1 ligand 1Homo sapiens (human)
protein bindingProgrammed cell death 1 ligand 1Homo sapiens (human)
receptor ligand activityProgrammed cell death 1 ligand 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (18)

Processvia Protein(s)Taxonomy
endoplasmic reticulum membraneCytochrome P450 1A2Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 1A2Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 1A2Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 2C9 Homo sapiens (human)
plasma membraneCytochrome P450 2C9 Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2C9 Homo sapiens (human)
cytoplasmCytochrome P450 2C9 Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2C9 Homo sapiens (human)
intracellular non-membrane-bounded organelleTAR DNA-binding protein 43Homo sapiens (human)
nucleusTAR DNA-binding protein 43Homo sapiens (human)
nucleoplasmTAR DNA-binding protein 43Homo sapiens (human)
perichromatin fibrilsTAR DNA-binding protein 43Homo sapiens (human)
mitochondrionTAR DNA-binding protein 43Homo sapiens (human)
cytoplasmic stress granuleTAR DNA-binding protein 43Homo sapiens (human)
nuclear speckTAR DNA-binding protein 43Homo sapiens (human)
interchromatin granuleTAR DNA-binding protein 43Homo sapiens (human)
nucleoplasmTAR DNA-binding protein 43Homo sapiens (human)
chromatinTAR DNA-binding protein 43Homo sapiens (human)
plasma membraneProgrammed cell death protein 1Homo sapiens (human)
external side of plasma membraneProgrammed cell death protein 1Homo sapiens (human)
nucleusProgrammed cell death 1 ligand 1Homo sapiens (human)
nucleoplasmProgrammed cell death 1 ligand 1Homo sapiens (human)
plasma membraneProgrammed cell death 1 ligand 1Homo sapiens (human)
actin cytoskeletonProgrammed cell death 1 ligand 1Homo sapiens (human)
early endosome membraneProgrammed cell death 1 ligand 1Homo sapiens (human)
recycling endosome membraneProgrammed cell death 1 ligand 1Homo sapiens (human)
extracellular exosomeProgrammed cell death 1 ligand 1Homo sapiens (human)
external side of plasma membraneProgrammed cell death 1 ligand 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (57)

Assay IDTitleYearJournalArticle
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID652615Cytotoxicity against human HepG2 cells by MTT assay2012Bioorganic & medicinal chemistry letters, Apr-01, Volume: 22, Issue:7
Anti-inflammatory and PPAR transactivational effects of secondary metabolites from the roots of Asarum sieboldii.
AID1209171Drug metabolism in human liver microsomes assessed as CYP450-mediated catecholization per mg of protein after 10 to 30 mins by HPLC analysis in presence of NADPH2012Drug metabolism and disposition: the biological fate of chemicals, Oct, Volume: 40, Issue:10
Comparison of metabolism of sesamin and episesamin by drug-metabolizing enzymes in human liver.
AID377133Antiplatelet activity against rabbit platelets assessed as inhibition of collagen-induced platelet aggregation at 20 ug/ml preincubated for 3 mins by turbidimetric method1999Journal of natural products, Jun, Volume: 62, Issue:6
Chemical constituents and biological activities of the fruit of Zanthoxylum integrifoliolum.
AID552866Cytotoxicity against human MCF7 cells after 3 days by MTT assay2011Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
Biologically active constituents from the fruiting body of Taiwanofungus camphoratus.
AID1209206Activity of recombinant human CYP1A2 expressed in Saccharomyces cerevisiae AH22 cells assessed as enzyme-mediated sesamin monocatecholization after 15 mins by Michaelis-Menten plot analysis in presence of NADPH2012Drug metabolism and disposition: the biological fate of chemicals, Oct, Volume: 40, Issue:10
Comparison of metabolism of sesamin and episesamin by drug-metabolizing enzymes in human liver.
AID377125Antiplatelet activity against rabbit platelets assessed as inhibition of arachidonic acid-induced platelet aggregation at 100 ug/ml preincubated for 3 mins by turbidimetric method1999Journal of natural products, Jun, Volume: 62, Issue:6
Chemical constituents and biological activities of the fruit of Zanthoxylum integrifoliolum.
AID381260Cytotoxicity against human KB cells
AID655420Transactivation of PPAR expressed in HepG2 cells after 20 hrs by luminescence assay2012Bioorganic & medicinal chemistry letters, Apr-01, Volume: 22, Issue:7
Anti-inflammatory and PPAR transactivational effects of secondary metabolites from the roots of Asarum sieboldii.
AID1546568Cytotoxicity against human SH-SY5Y cells after 72 hrs by MTT assay2020Bioorganic & medicinal chemistry, 01-01, Volume: 28, Issue:1
Artemisia: a promising plant for the treatment of cancer.
AID377138Antiplatelet activity against rabbit platelets assessed as inhibition of PAF-induced platelet aggregation at 20 ug/ml preincubated for 3 mins by turbidimetric method1999Journal of natural products, Jun, Volume: 62, Issue:6
Chemical constituents and biological activities of the fruit of Zanthoxylum integrifoliolum.
AID1209174Drug metabolism in Sprague-Dawley rat liver microsomes assessed as CYP450-mediated catecholization per mg of protein after 10 to 30 mins by HPLC analysis in presence of NADPH2012Drug metabolism and disposition: the biological fate of chemicals, Oct, Volume: 40, Issue:10
Comparison of metabolism of sesamin and episesamin by drug-metabolizing enzymes in human liver.
AID311533Cytotoxicity against mouse RAW cells2007Journal of natural products, Oct, Volume: 70, Issue:10
Trypanocidal and antileishmanial dihydrochelerythrine derivatives from Garcinia lucida.
AID1209202Activity of recombinant human CYP2C9 expressed in Saccharomyces cerevisiae AH22 cells assessed as enzyme-mediated sesamin monocatecholization after 15 mins by Michaelis-Menten plot analysis in presence of NADPH2012Drug metabolism and disposition: the biological fate of chemicals, Oct, Volume: 40, Issue:10
Comparison of metabolism of sesamin and episesamin by drug-metabolizing enzymes in human liver.
AID655417Inhibition of TNFalpha-induced NFkappaB transcriptional activity in human HepG2 cells pretreated for 1 hr before TNFalpha challenge by luciferase reporter gene analysis2012Bioorganic & medicinal chemistry letters, Apr-01, Volume: 22, Issue:7
Anti-inflammatory and PPAR transactivational effects of secondary metabolites from the roots of Asarum sieboldii.
AID1546569Cytotoxicity against mouse S17 cells after 72 hrs by MTT assay2020Bioorganic & medicinal chemistry, 01-01, Volume: 28, Issue:1
Artemisia: a promising plant for the treatment of cancer.
AID377122Antiplatelet activity against rabbit platelets assessed as inhibition of thrombin-induced platelet aggregation at 20 ug/ml preincubated for 3 mins by turbidimetric method1999Journal of natural products, Jun, Volume: 62, Issue:6
Chemical constituents and biological activities of the fruit of Zanthoxylum integrifoliolum.
AID1209212Drug metabolism in human liver microsomes assessed as CYP450-mediated catecholization after 10 to 30 mins by HPLC analysis in presence of NADPH2012Drug metabolism and disposition: the biological fate of chemicals, Oct, Volume: 40, Issue:10
Comparison of metabolism of sesamin and episesamin by drug-metabolizing enzymes in human liver.
AID552867Cytotoxicity against human HeLa cells after 3 days by MTT assay2011Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
Biologically active constituents from the fruiting body of Taiwanofungus camphoratus.
AID1209233Activity of recombinant human CYP2C19 expressed in Saccharomyces cerevisiae AH22 cells assessed as enzyme-mediated sesamin dicatechol/monocatechol formation at 2 to 20 uM after 15 mins by HPLC analysis in presence of NADPH2012Drug metabolism and disposition: the biological fate of chemicals, Oct, Volume: 40, Issue:10
Comparison of metabolism of sesamin and episesamin by drug-metabolizing enzymes in human liver.
AID377127Antiplatelet activity against rabbit platelets assessed as inhibition of arachidonic acid-induced platelet aggregation at 20 ug/ml preincubated for 3 mins by turbidimetric method1999Journal of natural products, Jun, Volume: 62, Issue:6
Chemical constituents and biological activities of the fruit of Zanthoxylum integrifoliolum.
AID673421Inhibition of rat intestinal maltase using maltose as substrate at 10 mg/ml preincubated for 10 mins before substrate addition by glucose oxidase method2012Bioorganic & medicinal chemistry letters, Aug-15, Volume: 22, Issue:16
(+)-Pinoresinol is a putative hypoglycemic agent in defatted sesame (Sesamum indicum) seeds though inhibiting α-glucosidase.
AID655418Inhibition of NFkappaB-mediated iNOS mRNA expression in human TNFalpha-stimulated human HepG2 cells pretreated for 1 hr before TNFalpha challenge measured after 6 hrs by RT-PCR analysis2012Bioorganic & medicinal chemistry letters, Apr-01, Volume: 22, Issue:7
Anti-inflammatory and PPAR transactivational effects of secondary metabolites from the roots of Asarum sieboldii.
AID377131Antiplatelet activity against rabbit platelets assessed as inhibition of collagen-induced platelet aggregation at 100 ug/ml preincubated for 3 mins by turbidimetric method1999Journal of natural products, Jun, Volume: 62, Issue:6
Chemical constituents and biological activities of the fruit of Zanthoxylum integrifoliolum.
AID377132Antiplatelet activity against rabbit platelets assessed as inhibition of collagen-induced platelet aggregation at 50 ug/ml preincubated for 3 mins by turbidimetric method1999Journal of natural products, Jun, Volume: 62, Issue:6
Chemical constituents and biological activities of the fruit of Zanthoxylum integrifoliolum.
AID477868Antituberculosis activity against Mycobacterium tuberculosis H37Ra by microplate alamar blue assay2010Journal of natural products, Apr-23, Volume: 73, Issue:4
Sesquiterpenes from Oplopanax horridus.
AID1209173Drug metabolism in Sprague-Dawley rat liver microsomes assessed as CYP450-mediated catecholization after 10 to 30 mins by HPLC analysis in presence of NADPH2012Drug metabolism and disposition: the biological fate of chemicals, Oct, Volume: 40, Issue:10
Comparison of metabolism of sesamin and episesamin by drug-metabolizing enzymes in human liver.
AID1209207Activity of recombinant human CYP1A2 expressed in Saccharomyces cerevisiae AH22 cells assessed as Kcat/Km for enzyme-mediated sesamin monocatecholization after 15 mins by Michaelis-Menten plot analysis in presence of NADPH2012Drug metabolism and disposition: the biological fate of chemicals, Oct, Volume: 40, Issue:10
Comparison of metabolism of sesamin and episesamin by drug-metabolizing enzymes in human liver.
AID1661026Inhibition of human PD1/PDL1 protein-protein interaction by HTRF assay
AID377126Antiplatelet activity against rabbit platelets assessed as inhibition of arachidonic acid-induced platelet aggregation at 50 ug/ml preincubated for 3 mins by turbidimetric method1999Journal of natural products, Jun, Volume: 62, Issue:6
Chemical constituents and biological activities of the fruit of Zanthoxylum integrifoliolum.
AID552864Cytotoxicity against human DaOY cells after 3 days by MTT assay2011Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
Biologically active constituents from the fruiting body of Taiwanofungus camphoratus.
AID1209234Ratio of Kinact to Ki(app) for mechanism-based inhibition of recombinant human CYP2C9 expressed in microsomes isolated from Saccharomyces cerevisiae AH22 cells assessed as diclofenac 4'-hydroxylation preincubated for 5 to 10 mins followed by substrate add2012Drug metabolism and disposition: the biological fate of chemicals, Oct, Volume: 40, Issue:10
Comparison of metabolism of sesamin and episesamin by drug-metabolizing enzymes in human liver.
AID779150Inhibition of Wnt/beta-catenin signaling pathway in human HEK293 cells at 20 uM after 24 hrs by dual luciferase reporter gene assay relative to vehicle-treated control2013Bioorganic & medicinal chemistry letters, Oct-15, Volume: 23, Issue:20
Anti-proliferative activity of hydnocarpin, a natural lignan, is associated with the suppression of Wnt/β-catenin signaling pathway in colon cancer cells.
AID673424Inhibition of bakers yeast alpha-glucosidase using p-nitrophenyl-(alpha-D-glucopyranoside) as substrate preincubated for 10 mins before substrate addition by microplate reader2012Bioorganic & medicinal chemistry letters, Aug-15, Volume: 22, Issue:16
(+)-Pinoresinol is a putative hypoglycemic agent in defatted sesame (Sesamum indicum) seeds though inhibiting α-glucosidase.
AID423018Antiinflammatory activity against human neutrophils assessed as inhibition of fMLP/CB-induced elastase release2009Journal of natural products, Jan, Volume: 72, Issue:1
Amides and benzenoids from Zanthoxylum ailanthoides with inhibitory activity on superoxide generation and elastase release by neutrophils.
AID289114Inhibition of fMLP-induced superoxide production in human neutrophils2007Journal of natural products, Jun, Volume: 70, Issue:6
Anti-inflammatory benzenoids from Antrodia camphorata.
AID1209203Activity of recombinant human CYP2C9 expressed in Saccharomyces cerevisiae AH22 cells assessed as Kcat/Km for enzyme-mediated sesamin monocatecholization after 15 mins by Michaelis-Menten plot analysis in presence of NADPH2012Drug metabolism and disposition: the biological fate of chemicals, Oct, Volume: 40, Issue:10
Comparison of metabolism of sesamin and episesamin by drug-metabolizing enzymes in human liver.
AID1169294Inhibition of TTR V30M mutant (unknown origin) expressed in Escherichia coli assessed as inhibition of amyloid fibril formation at 20 uM by fluorescence assay2014Journal of medicinal chemistry, Nov-13, Volume: 57, Issue:21
Inhibitory activities of propolis and its promising component, caffeic acid phenethyl ester, against amyloidogenesis of human transthyretin.
AID655419Inhibition of NFkappaB-mediated COX2 mRNA expression in human TNFalpha-stimulated human HepG2 cells by RT-PCR analysis2012Bioorganic & medicinal chemistry letters, Apr-01, Volume: 22, Issue:7
Anti-inflammatory and PPAR transactivational effects of secondary metabolites from the roots of Asarum sieboldii.
AID586667Induction of NRF2/ARE enhancer activity rat PC12 cells transfected with ARE-firefly luciferase reporter gene at 10 uM after 24 hrs by luciferase assay2011Bioorganic & medicinal chemistry, Mar-15, Volume: 19, Issue:6
Involvement of heme oxygenase-1 induction via Nrf2/ARE activation in protection against H2O2-induced PC12 cell death by a metabolite of sesamin contained in sesame seeds.
AID1209214Drug metabolism in human liver microsomes assessed as sesamin monocatechol formation after 30 mins by HPLC analysis in presence of NADPH2012Drug metabolism and disposition: the biological fate of chemicals, Oct, Volume: 40, Issue:10
Comparison of metabolism of sesamin and episesamin by drug-metabolizing enzymes in human liver.
AID423017Antiinflammatory activity against human neutrophils assessed as inhibition of fMLP/CB-induced superoxide anion generation2009Journal of natural products, Jan, Volume: 72, Issue:1
Amides and benzenoids from Zanthoxylum ailanthoides with inhibitory activity on superoxide generation and elastase release by neutrophils.
AID1546567Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay2020Bioorganic & medicinal chemistry, 01-01, Volume: 28, Issue:1
Artemisia: a promising plant for the treatment of cancer.
AID673419Inhibition of rat intestinal sucrase using sucrose as substrate at 10 mg/ml preincubated for 10 mins before substrate addition by glucose oxidase method2012Bioorganic & medicinal chemistry letters, Aug-15, Volume: 22, Issue:16
(+)-Pinoresinol is a putative hypoglycemic agent in defatted sesame (Sesamum indicum) seeds though inhibiting α-glucosidase.
AID552865Cytotoxicity against human Hep2 cells after 3 days by MTT assay2011Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
Biologically active constituents from the fruiting body of Taiwanofungus camphoratus.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (419)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (0.72)18.7374
1990's33 (7.88)18.2507
2000's88 (21.00)29.6817
2010's208 (49.64)24.3611
2020's87 (20.76)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.01

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.01 (24.57)
Research Supply Index6.08 (2.92)
Research Growth Index5.86 (4.65)
Search Engine Demand Index93.40 (26.88)
Search Engine Supply Index3.98 (0.95)

This Compound (34.01)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials9 (2.10%)5.53%
Reviews19 (4.43%)6.00%
Case Studies2 (0.47%)4.05%
Observational0 (0.00%)0.25%
Other399 (93.01%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]